Document is current
Any future updates will be listed below
-
Authors
Guillo, Lucas https://orcid.org/0000-0001-9024-8541
Grimaud, Fanny
Houser, Fanny
Prost, Caroline
Jouve, Elisabeth
Philandrianos, Cécile
Abellan, Maxime
Veran, Julie
Visee, Carine
Beyer-Berjot, Laura
Desjeux, Ariadne
Dignat-George, Françoise
Leone, Marc
Grimaud, Jean-Charles
Sabatier, Florence
Serrero, Mélanie
Magalon, Jérémy
- License Information
-
More Information
Article History
Received: 10 May 2021
Accepted: 20 January 2022
First Online: 9 February 2022
Declarations
:
: The protocol was approved by the national ethics committee, and each patient gave written informed consent. The study was conducted according to the Declaration of Helsinki, as well as relevant international, national and local rules and regulations.
: Not applicable.
: L Guillo declares consulting fees for AbbVie. JC Grimaud has served as a consultant for AbbVie, Takeda and Janssen and as a speaker for AbbVie, Takeda, Janssen and MSD. M Serrero declares lecture and consulting fees for AbbVie, Celltrion, Ferring, Janssen, MSD, Takeda and Tillotts. JM received honorarium for educational support from FIDIA, HORIBA and MACOPHARMA. The remaining authors declare no conflict of interest.
